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Abstract
Background: Postmenopausal osteoporosis (PMO) is an estrogen deficiency condition that causes severe loss of bone mass in the vertebrae and
long bones. We explored the effect and the possible underlying mechanism of the extracts of Astragalus (AE) on the tooth alveolar bone
rebuilding progress of postmenopausal osteoporosis of PMO animal models.
Material and methods: The PMO models were acquired by ovariectomy. After 8 weeks the first left maxillary molars of the rats were extracted
and AE was administered orally for 8 weeks. Then the histological morphology and the transcription and expression of TGF-β1 and TNF-α in the 
tooth extracted socket were detected by HE dying, QRT-PCR and ELISA.
Results: The results showed that the new bone volume and TGF-β1 was significantly lower in PMO group than the control group and AE group 
at the observing period. At the same time TNF-α in PMO group was significantly higher than the other two groups. Moreover AE group had no 
significant differences with the control group in all data at the observing period.
Conclusion: AE has positive effect on alveolar bone rebuilding progress of tooth extracted socket of PMO rats. AE also has the potential to
enhance the expression of TGF-β1and decrease the expression of TNF-α of the rebuilding tooth extracted socket.  
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Introduction
Postmenopausal osteoporosis (PMO) is an estrogen deficiency condition that causes severe loss of bone mass in the vertebrae and long bones.
The impact of PMO is expected to increase quickly (Johnell et al, 2006; Reginster et al, 2006). PMO not only leads to osteoporotic fractures of
vertebrae and long bones, but also has a positive relationship with some jaw pathologic conditions, such as oral bone loss (Payne etal, 2000;
Bollen etal, 2000; Steinberg et al, 1999; Southard et al, 1999), low mineral density in the mandible (Lee et al, 2005; Takaishi et al, 2005) and
severity of residual ridge re-absorption (Hirai et al, 1993; Jonasson et al, 2005). The jaw bones are very important for oral functions such as
mastication, swallowing, and pronunciation. In contrast to other bones, they are the base of preserving nature teeth and supporting artificial teeth
after nature teeth losing, which are essential to raise the life quality of elderly people. Consequently, it is necessary for the dentists and
researchers to study the correlation between PMO and jaw bones mass and find out effective and safe ways to prevent bone loss of alveolar and
jaw.
Now the prescription drugs used to treat osteoporosis mainly include bisphosphonates，estrogen, selective estrogen receptor modulators,
parathyroid hormone and so on. The drugs play an important part in preventing accelerated bone loss and decreasing age-related decreases in
bone density, however, they have their own contraindications or adverse effects respectively (Rossouw et al, 2002; Woo et al, 2006; Beral et al,
2003; Barrett-Connor et al, 2006;). And all these drugs only have the single effect. Multiple traditional Chinese medicine formulas and their
monomer ingredients were proved being effective on treating osteoporosis and the mechanisms were the focus of research too. The phytoestrogen
was the mainly effective composition with relatively less side-effects comparing with HRT (Zhao et al, 2012). The extracts of AE are a kind of
Chinese traditional medicine which includes polysaccharides, saponins, and flavonoids. These three major chemical classes contribute to the
multiple bioactivities of Astragalus (Yang et al, 2013). And one of AE biological functions is anti-osteoporosis activity. (Kim et al, 2003). In this
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study, we investigated the effect of AE on alveolar bone rebuilding progress of teeth extracted socket on animal model of PMO.
Material and methods
Animal and groups
Sixty 3-month-old female Sprague-Dawley (SD) rats were randomly divided into two groups. 20 rats were brought into the control group,
which underwent sham surgery and rest 40 rats were ovariectomized bilaterally. 8 weeks after operation the first left maxillary molar of all rats
were extracted. The rats receiving ovariectomy then were randomly divided into non-treated group (PMO group, n=20) and AE treated group (AE
group, n=20). Rats in the AE group received AE intra-gastric administration (10μl/kg) everyday. Rats in the control group and PMO group 
received the same volume distilled water intra-gastric administration. At 4w and 8w after extraction, 10 rats of each group were sacrificed
respectively. The left maxillas were excised. The specimens were for histological observation, quantitative reverse transcription -polymerase
chain reaction (QRT-PCR) and enzyme linked immunosorbent assay (ELISA).
Histological observation
The specimens were fixed in 4% paraform (Shanghai Suolaibao biotechnology, Shanghai, China) for 3 days, decalcified in 10% ethylene
diamine tetraacetic acid (EDTA pH 7.4; Sigma, Steinheim, Germany) for 1 month, dehydrated with increasing concentrations of ethanol, and
embedded in paraffin (Active motif, Carlsbad, CA, USA). The acquired blocks were unilaterally cut to the sagittal plane, which was
perpendicular to occlusal plane and penetrated the wound of the first molar extracted. The specimens were then cut into 5μm sections by 
microtom. 5 sections of each specimen were stained by hematoxylin and eosin (HE) for histological observation.
Quantitative real-time polymerase chain reaction (QRT-PCR)
The specimens for QRT-PCR were taken and frozen at -80°C for 30mins and then transferred to liquid nitrogen until RNA extraction. For
analysis frozen samples (100mg) were crushed in an achate mortar under liquid nitrogen and homogenized in 1ml precool Trisol (Invitrogen,
Carlsbad, CA, USA) solution. After adding 200μl chloroform (Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 5mins on the ice, in-soluble 
material was removed by centrifugation (12,000rpm, 15mins, 4 oC). 400μl supernatant were mixed with 400μl sopropanol(Aladdin, Shanghai, 
China) for 10mins on ice which then was under centrifugation (12,000rpm, 15mins, 4 oC). RNA was acquired after the in-soluble material was
eluted by 1ml absolute alcohol followed by centrifugation (7500 rpm, 10 mins, 4 oC) and dissolution in 30 μl RNase-free H2O.
Reverse-transcribed method accorded the manufacturer’s instructions. QRT-PCR analysis was carried out in an Applied Biosystems 7500 Fast
(Applied,BiosystemsCarlsbad, CA, USA). Primer sequences used to amplify TGF-β1 and TNF-α, and glyceraldehyde phosphate dehydrogenase 
(GAPDH), an internal reference, are listed in Table 1
Table 1: Sequences of primer sets for quantitative real-time PCR













To quantify the protein concentration of  TGF-β1 and TNF-α, ELISA methods were used. The specimens for ELISA were taken and frozen 
at -80 °C for 30 mins and then transferred to liquid nitrogen until protein extraction. For extract preparation, frozen samples were ground in a
prcooled sterile achate mortar and dissolved in 600-800μl lysis buffer, which consisted of 100 μg/ml bovine serum albumin (Sigma), 100 μg/ml 
Zwittergent-12 (Boehringer-Mannheim,Indianapolis, Ind., USA), 50 μg/ml Garamycin (Schering-Plough, Brussels, Belgium), 10 mM Hepes 
buffer (Life Technologies, Paisley, Scotland, UK), 1μg/ml aprotinin (Sigma), 1 μg/ml leupeptin (Sigma), 0.1 μM EDTA (Sigma), in RPMI-1640 
(Sigma). The samples were then centrifuged at 12,000 rpm and the supernatant was stored at –80°C and then assayed for TGF-β1 and TNF-α with 
commercially available ELISA kits (R&D, Minneapolis, MN). The analyses were performed according to the instructions of the manufacturer.
The concentration of TGF-β1 and TNF-α was calculated with reference to the standards provided by each kits. Results were expressed as pg 
cytokine/mg tissue.
Statistical analysis
One way ANOVA and Tukey’spost hoctests were used to evaluate statistical significance of the difference among 3 groups. The SPSS 16.0
version for Windows (SPSS Inc., Chicago, IL) was used for the statistical analysis. P values less than 0.01 were considered statistically
significant.
Results
Bone alternation of the tooth extraction wound
Bone formation was found in the tooth extraction wound at 4w and 8w by HE staining (Fig 1). In each group new bone volume was
significantly lower at 4w than at 8w. At 4w, the trabecular number was significantly lower in the PMO group than in the control group.
Accordingly, the trabecular separation was significantly higher in the PMO group than in the control group. At 8w, the trabecular of the PMO
group was fragmented and seemed to form isolated islands in the large bone marrow. In contrast, the trabecular connected with each other and
formed network structures with smaller bone marrow in the control group. And the histological characters in the AE group in every period were
similar with control group.
Figure 1: Bone formation in the tooth extraction wound in the control group (A and D at 4w and 8w)， PMO group (B and E at 4w and 8w) and
AE group (C and F at 4w and 8w). Estrogen deprivation caused a decrease in new bone formation of healing progress of tooth extraction wound
in 4w and 8w (A compared with B, D compared with E). There was no significant difference in new bone volume between the control group and
the AE group (A compared with C, D compared with F), which proved that AE could decreased negative effect of estrogen to the new bone
formation of the tooth extraction wound.
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The alternation of TGF-β1of the tooth extraction wound
TGF-β1 mRNA was expressed in all the tooth extraction wound tissue in every period. The obvious increase of TGF-β1 mRNA was 
observed in control group and the AE group than in the PMO group at 4w. It decreased from 4w to 8w in all three groups and still significantly
lower in the PMO group than in the other two groups at 8w. Meanwhile the expression of TGF-β1 mRNA had no significant difference between 
the control group and the AE group over the period of observation (Fig 2A).
The expression of TGF-β1 protein had the same tendency with its gene expression, which was significantly lower in the PMO group than in 
the other two groups at 4w. The AE group has no significant difference with the control group in the amounts of TGF-β1 protein. Although the 
TGF-β1 protein in the tooth extraction wound tissue showed a statistically significant decline at 8w in every group, the PMO group still expressed 
the least TGF-β1 protein in the three groups significantly, with no significant difference between the control group and the AE group (Fig 2B). 
Figure2:  mRNA and protein expression alternation of TGF-β1 in the control group, PMO group and AE group at 4w and 8w after tooth 
extraction. AE increased the mRNA expression (A) and protein expression (B) of TGF-β1 in the tooth alveolar bone rebuilding progress, which 
was down-regulated by estrogen deficiency in the PMO group. **, P<0.01, compared with the control group. ##, P<0.01, compared with
PMO group.
The alternation of TNF-α of the tooth extraction wound  
TNF-α mRNA was expressed in all the tooth extraction wound tissue. The mRNA for TNF-α was significantly higher in the PMO group than 
the control group and the AE group at 4w and 8w. Meanwhile no obvious difference was observed between the control group and the AE group at
4w and 8w（Fig 3A).
Fig 3B showed that the TNF-α protein in the PMO group were significantly higher than the control group and the AE group at 4w and 8w, 
despite an obvious decline from 4w to 8w in every group independently. No significant differences were observed between the control group and
the AE group in the amounts of TNF-α protein at 4w and 8w. The expression of TNF-α protein had the same tendency with its gene expression. 
Figure 3: mRNA and protein expression alternation of TNF-α in the control group, PMO group and AE group at 4w and 8w after tooth 
extraction. AE lowered the mRNA expression(A) and protein expression(B) of TNF-α in the tooth alveolar bone rebuilding progress, which was 
up-regulated by estrogen deficiency in the PMO group. **, P<0.01, compared with the control group. ##, P<0.01, compared with PMO group.
Discussion
The ovariectomized (OVX) rat model is used widely as a preclinical model to evaluate bony changes that occurs with estrogen deﬁciency in 
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postmenopausal osteoporosis (Kalu et al, 1991; Nishida etal, 2004; Boyd et al, 2006; Jeong-Hyun et al, 2010; Thompson et al, 1995). We used
OVX rat model to examine the effects of AE on bony healing progress after tooth extraction. The normal metabolism of bone is composed by
bone re-absorption and formation, called bone remodeling. Under the condition of osteoporosis the bone remodeling is unbalanced. The initiation
of bone remodeling is induced rapidly and the resorptive and formative phases of remodeling are both enhanced, and the resorptive phases is
faster than formative phases which results in the lost of bone. Shimizu reported that in comparison to sham-operated controls, new bone formation
in OVX rats was slightly increased in the early phase but subsequently showed a marked decrease. Bone resorption in OVX rats was greatly
stimulated and was comparatively long-lasting (Shimizu, 1998; Shimizu, 2000). Pereira reported the results with the similar tendency（Pereira et
al, 2007）. Our results showed that new bone volume of tooth extraction socket was lower in PMO group compared with the control group，which
suggested that estrogen deprivation caused a decrease in new bone formation of healing progress of tooth extraction wound. While we did not see
a significant difference in new bone volume between the control group and the AE group, which proved that the negative effect of estrogen
deficiency to the new bone formation of the tooth extraction wound could been decreased by AE.
TGF-β1 is recognized as the powerful promoter of bone formation. It is produced by osteoblasts and other bone cells and affects osteoblast 
proliferation and differentiation. And it also incorporates into mineralized bone matrix. In most studies, it increased expression of markers of
osteoblast differentiation, such as alkaline phosphatase, type I collagen, and osteonectin (Ingram et al, 1994; Stron et al, 1990; Wergedal et al,
1992). TGF-β1 is expressed at high levels in mature osteoblasts on bone surfaces during bone development and growth (Dodds et al, 1993; D’ 
Souza et al, 1994) and in healing fracture callus (Joyce et al, 1990; Sandberg et al, 1993). The healing of the tooth extraction wound is similar to
the bone fracture. Therefore TGF-β1 may play a pivotal role in bone wound healing progress especially in bone formation. 
Ikeda’s research demonstrated that three weeks after ovariectomy TGF-β1 mRNA levels from the tibiae of rats had 70%-80% decrease 
compared with the sham-operated group and ovariectomy caused 15% reduction in femoral bone mineral density as early as two weeks
post-operation, which provide the evidence that expression of TGF-β1 was reciprocally regulated at the transcriptional level in estrogen deficient 
condition and suggests that TGF-β1 may play a role in estrogen-dependent maintenance of normal bone density (Ikeda et al, 1993). Therefore we 
can conclude from these studies that estrogen deficiency induced by overiectomy can lowered the expression of TGF-β1 in bone. Due to the 
important function of TGF-β1 in bone formation, it can be implied that one of mechanism that estrogen deficiency induce bone loss is from its 
negative effect on the expression of TGF-β1. 
TNF-α plays a major role in osteoclastogenesis. It was reported to induce the formation of osteoclastic cells from bone marrow 
macrophages in vitro (Kobayashi et al, 2000; Azuma et al, 2000) and TNF-α-induced osteoclast recruitment is probably central to the 
pathogenesis of bone disorders (Wong et al, 2008). TNF-α causes osteoclast-induced bone destruction as well as the inhibition of osteoblast 
differentiation and apoptosis (Lu et al, 2006). TNF-α has an inhibitory effect during various stages of osteoblast differentiation and can act on 
osteoblast precursor cells during the early stages of differentiation to inhibit insulin-like growth factor 1, which increases the differentiation of
osteoblast precursor cells from stem cells (Gilbert et al, 2002). TNF-α acts on osteoblasts to inhibit the transcription of runt-related transcription 
factor 2 (RUNX2), the main transcription factor for osteoblast differentiation, by inducing the degradation of RUNX2 mRNA (Gilbert et al,
2000).Therefore TNF-α may play a key role in bone metabolism and is important in patho-logical bone loss.  
Many studies proved that a key mechanism by which estrogen deficiency induces bone loss is that estrogen deficiency enhances T cell
production of TNF-α. Roggia found that ovariectomy increased the number of bone marrow T cell and induced more TNF-α further. Meanwhile 
the bone loss induced by ovariectomy was absent in T cell-deficient nude mice (Roggia et al, 2001). Simone got the similar result that
ovariectomy failed to induce bone loss in T-cell deficient mice (Simone et al, 2000). Furthermore injection of TNF-α-binding protein that 
neutralizes TNF-α was shown to protect ovariectomized rat against bone loss by inhibiting osteoclast formation (Kimble et al, 1997). Roggia 
observed that TNF-α knock-out mice (TNF-/-), as well as transgenic mice without thymus (and therefore without mature T cell), did not lose bone 
after ovariectomy (Roggia et al, 2004). All These findings demonstrated the ability of estrogen to target T cells, suppressing their production of
TNF-α, is a key mechanism by which estrogen prevents osteoclastic bone resorption and bone loss. 
In this study the transcription and expression of TGF-β1 in the healing of extraction sockets were lower in the PMO group than the control 
group, while the transcription and expression of TNF-α were higher in the PMO group than the control group. All these results accorded with the 
previous studies. At the same time we founded that AE not only enhanced the transcription and expression of TGF-β1 in the healing of extraction 
sockets in ovariectomized rats significantly, but also lowered the transcription and expression of TNF-α under PMO condition. Many previous 
reports showed components of AE had effected the pathway of TGF-β1/Smad signaling and the production of TNF-α in different cells and tissues. 
(Hu etal, 2014; Qu etal, 2012; Jung etal, 2013). The findings of this study showed the positive effect of AE on TGF-β1 and negative effect on 
TNF-α in bone tissue under the condition of PMO, which provided insights on the mechanism of the stimulatory effect of AE on the bone healing 
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progress of tooth extraction under PMO condition. AE increased the production of TGF-β1 which was down-regulated by estrogen deficiency as 
well as lowered the production of TNF-α which was up-regulated by estrogen deficiency.  The bone resorption induced by TNF-α under the 
condition of PMO was decreased by AE and the increased TGF-β1 by AE enhanced the new bone formation under such condition.  
Conclusion
Ovariectomy caused a decrease in new bone formation of healing progress of tooth extraction wound, which could be prevented by AE through
enhancing the production of TGF-β1 which was limited by estrogen deficiency and lowering the secretion of TNF-α which was promoted by 
estrogen deficiency.
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